|1.||McNagny, Kelly M: 7 articles (01/2015 - 08/2004)|
|2.||Roskelley, Calvin D: 5 articles (01/2015 - 08/2004)|
|3.||Larrucea, Susana: 4 articles (11/2015 - 01/2006)|
|4.||Konstantopoulos, Konstantinos: 4 articles (09/2015 - 01/2009)|
|5.||Hara, Masanori: 4 articles (05/2015 - 02/2005)|
|6.||Fermér, Christian: 4 articles (01/2015 - 01/2014)|
|7.||Hagström, Jaana: 4 articles (01/2015 - 01/2014)|
|8.||Nielsen, Julie S: 4 articles (01/2015 - 08/2004)|
|9.||Nilsson, Olle: 4 articles (01/2015 - 01/2014)|
|10.||Haglund, Caj: 4 articles (01/2015 - 01/2014)|
07/01/2014 - "ABT702 also reduced albuminuria and markers of glomerular injury, nephrinuria and podocalyxin excretion levels, in diabetic mice. "
12/01/2015 - "On a biochemical scale, kidney functions, albuminuria, urinary nephrin, podocalyxin excretion, and host oxidant/antioxidant balance significantly improved. "
04/01/2012 - "ManNAc treatment appeared to ameliorate the hyposialylation status of mutant mice, indicated by a lectin histochemistry pattern similar to that of wild-type mice, with improved sialylation of both nephrin and podocalyxin, as well as reduced albuminuria compared with untreated mutant mice. "
01/01/1992 - "Loss of glomerular polyanion correlated with albuminuria in experimental cadmium nephropathy."
01/01/2013 - "Urinary nephrin, podocalyxin, TRPC6, podocin, and alpha actinin-4 were correlated with glycemic control and albuminuria but not with renal function. "
01/01/2012 - "Novel flow cytometric method for the detection of podocalyxin-positive elements in urine of patients with glomerulonephritides - first promising results."
01/01/2008 - "Using anti-podocalyxin monoclonal antibody, PCX+EL were counted by FACS in 38 patients with various types of active glomerulonephritis, 15 patients with chronic glomerulonephritis in long-term remission and 44 healthy controls. "
01/01/1995 - "Podocalyxin was detected in the urinary sediments of patients with various forms of glomerulonephritis, particularly those with acute onset. "
01/01/1995 - "Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis."
01/01/1986 - "The results show that peripheral mononuclear blood cells from subjects with minimal-change nephrotic syndrome had affected glomerular polyanion in vitro during incubation with kidney tissue in a significantly (p less than or equal to 0.005) higher number of cases (15/17) as compared with the number of glomerulonephritis patients who scored positive in 4 out of 14 cases, whereas this was the case in 3 out of 18 cases of the normal donors. "
01/01/2006 - "In conclusion, revealed in our study diminished immunoexpression of podocalyxin and significant correlation with the level of proteinuria in FSGS patients suggests a possible role of this sialoprotein in the alteration of the glomerular filtration barrier in this disease."
01/01/2006 - "The immunostaining of CD2AP and alpha-actinin-4 did not correlate with the intensity of proteinuria in patients with MCD, FSGS and IgAN, whilst in FSGS patients the significant correlation was found between the glomerular immunostaining of podocalyxin and proteinuria. "
09/01/1996 - "In PAN, defective sialylation of a major sialoprotein of podocytes, podocalyxin, has been demonstrated and the consequent decrease of anionic charge suggested as a causative factor for increased glomerular permeability and proteinuria. "
11/14/1988 - "The proteinuria of aging is therefore due to moderate increases in glomerular permeability and, more importantly, to loss of fixed glomerular polyanion. "
05/01/1983 - "Loss of characteristic staining for both glomerular sialoprotein and discrete anionic sites in the GBM coincided with early epithelial cell alterations and occurred prior to the onset of measurable proteinuria."
09/19/2008 - "In this study, 51 astrocytic tumors were investigated for podocalyxin expression using immunohistochemistry, Western blot analysis, and quantitative real-time PCR. "
09/19/2008 - "The aim of this study is to examine the relationship between podocalyxin expression and malignant progression of astrocytic tumors. "
03/01/2007 - "Since the initial discovery of podocalyxin in a cancerous stem cell, numerous new studies have identified podocalyxin in many different human cancers and in embryonic stem cells lines (ES) derived from human embryos. "
09/01/2015 - "High expression levels of podocalyxin (PCX) have been shown to be correlated with poor outcome in various types of cancer. "
01/01/2015 - "The associations of the podocalyxin tumor expression with clinicopathological variables were explored by Fisher's exact test and the linear-by-linear test. "
|5.||Nephrotic Syndrome (Syndrome, Nephrotic)
05/01/2012 - "To study the clinical significance of urinary podocyte marker protein podocalyxin (PCX) in the diagnosis of primary nephrotic syndrome (PNS) in children and the evaluation of disease severity. "
02/01/2011 - "This is one of the few studies investigating podocalyxin immunohistochemical expression in glomerulopathies associated with nephrotic syndrome. "
02/01/2011 - "The aim of this study was to investigate the role of podocalyxin, a major podocyte protein, in the pathogenesis of glomerulopathies primarily associated with the nephrotic syndrome. "
05/01/2012 - "[Clinical significance of determining urinary podocalyxin level in children with primary nephrotic syndrome]."
02/01/2011 - "The observed reduction in podocalyxin expression suggests that it constitutes a target molecule in nephrotic syndrome pathogenesis regardless of the underlying cause."
|6.||Membrane Glycoproteins (Membrane Glycoprotein)
|8.||GTP-Binding Proteins (G-Protein)
|9.||RNA-Directed DNA Polymerase (Reverse Transcriptase)
|10.||macrophage stimulatory lipopeptide 2